Position in BNTX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$264,951
+$163,911 QoQ
Shares Held
2,981
+214.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Brooklyn Investment Group holds $22,842,973 across 42 Biotechnology names. BNTX ranks #30 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,245 | $2,788,642 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,889 | $1,459,516 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
50,312 | $1,393,642 | |
| 4 | ARGX |
Argenx SE
|
1,697 | $1,239,234 | |
| 5 | MRNA |
Moderna, Inc.
|
23,110 | $1,173,988 | |
| 6 | GMAB |
Genmab A/S
|
35,823 | $961,131 | |
| 7 | ASND |
Ascendis Pharma A/S
|
4,072 | $931,388 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
8,994 | $874,666 |
All Filings in BNTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $264,951 | 2,981 | Shares | Defined | 2026-04-29 | |
| 2025-06-30 | $101,040 | 949 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,308 | 234 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,092 | 150 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $10,808 | 91 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||